<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460299</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101132</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">The transplacental vertical transfer of maternal antibodies was determined to be a crucial factor in conferring protective immunity to infants following delivery, and this study aimed to evaluate the protective effect of maternal preconception COVID-19 vaccination on infants.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted at the National Clinical Medical Research Center for Child Health and Diseases in Chongqing, China, spanning from July 2022 to April 2023. The study included infants from mothers with a preconception COVID-19 vaccination and (or) a SARS-CoV-2 infection during pregnancy. Titers of SARS-CoV-2 immunoglobulin G (IgG) and cross-neutralizing activity against SARS-CoV-2 variants were detected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this cohort study comprising 158 infants, it was observed that infants born to mothers who experienced a pregnancy-related breakthrough infection following a preconception vaccination had the highest titers of SARS-CoV-2 IgG and cross-neutralizing antibody activity against different variants compared to those with either of these factors alone. The transplacental vertical transmission of anti-SARS-CoV-2 antibodies decreased significantly with increasing age, from 3.16 ODs at birth to 2.29 ODs at two months, and persisted for approximately four months after birth. The predominant subclass of passively transmitted antibodies via the placenta was found to be IgG1, and a positive correlation was observed between the titers of SARS-CoV-2 IgG and IgG1 (R = 0.59, <i>p</i> &lt; 0.001; Slope: 0.49 Â± 0.070, <i>p</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Maternal preconception COVID-19 vaccination represents a promising immunological strategy for conferring postnatal protection to infants, especially during the period of heightened risk of exposure to SARS-CoV-2 infection. It is imperative to underscore the significance of vaccination for women who are preparing to become pregnant or are pregnant, and concerted efforts must be made to promote vaccination among eligible women.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Bishan Hospital of Chongqing Medical University, Chongqing 402760, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Haijun</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4890-192X</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dapeng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guojin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Huiwu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yihan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ni</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5830-8786</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4550-9436</Identifier><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400015, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CQYC20210303393</GrantID><Agency>Chongqing Talent Program</Agency><Country /></Grant><Grant><GrantID>none</GrantID><Agency>Program for Youth Innovation in Future Medicine, Chongqing Medical University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">infants</Keyword><Keyword MajorTopicYN="N">maternal immune</Keyword><Keyword MajorTopicYN="N">protective effect</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460299</ArticleId><ArticleId IdType="pmc">PMC11511423</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101132</ArticleId><ArticleId IdType="pii">vaccines12101132</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marks K.J., Whitaker M., Agathis N.T., Anglin O., Milucky J., Patel K., Pham H., Kirley P.D., Kawasaki B., Meek J., et al. Hospitalization of Infants and Children Aged 0â4 Years with Laboratory-Confirmed COVID-19âCOVID-NET, 14 States, March 2020âFebruary 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:429â436. doi: 10.15585/mmwr.mm7111e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7111e2</ArticleId><ArticleId IdType="pmc">PMC8942304</ArticleId><ArticleId IdType="pubmed">35298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X., Zhao Z., Zhang T., Guo W., Guo W., Zheng J., Zhang J., Dong C., Na R., Zheng L., et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19) J. Med. Virol. 2021;93:1057â1069. doi: 10.1002/jmv.26398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26398</ArticleId><ArticleId IdType="pmc">PMC7436402</ArticleId><ArticleId IdType="pubmed">32761898</ArticleId></ArticleIdList></Reference><Reference><Citation>Etti M., Calvert A., Galiza E., Lim S., Khalil A., Le Doare K., Heath P.T. Maternal vaccination: A review of current evidence and recommendations. Am. J. Obstet. Gynecol. 2022;226:459â474. doi: 10.1016/j.ajog.2021.10.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.10.041</ArticleId><ArticleId IdType="pmc">PMC8582099</ArticleId><ArticleId IdType="pubmed">34774821</ArticleId></ArticleIdList></Reference><Reference><Citation>Halasa N.B., Olson S.M., Staat M.A., Newhams M.M., Price A.M., Boom J.A., Sahni L.C., Cameron M.A., Pannaraj P.S., Bline K.E., et al. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine during Pregnancy against COVID-19-Associated Hospitalization in Infants Aged &lt;6 Monthsâ17 States, July 2021âJanuary 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:264â270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853480</ArticleId><ArticleId IdType="pubmed">35176002</ArticleId></ArticleIdList></Reference><Reference><Citation>Halasa N.B., Olson S.M., Staat M.A., Newhams M.M., Price A.M., Pannaraj P.S., Boom J.A., Sahni L.C., Chiotos K., Cameron M.A., et al. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N. Engl. J. Med. 2022;387:109â119. doi: 10.1056/NEJMoa2204399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204399</ArticleId><ArticleId IdType="pmc">PMC9342588</ArticleId><ArticleId IdType="pubmed">35731908</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsen E., Magnus M.C., Oakley L., Fell D.B., Greve-Isdahl M., Kinge J.M., HÃ¥berg S.E. Association of COVID-19 Vaccination during Pregnancy with Incidence of SARS-CoV-2 Infection in Infants. JAMA Intern. Med. 2022;182:825â831. doi: 10.1001/jamainternmed.2022.2442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.2442</ArticleId><ArticleId IdType="pmc">PMC9161123</ArticleId><ArticleId IdType="pubmed">35648413</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Xing H., Zhao Y. Transplacental transmission of SARS-CoV-2 immunoglobulin G antibody to infants from maternal COVID-19 vaccine immunization before pregnancy. J. Med. Virol. 2023;95:e28296. doi: 10.1002/jmv.28296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28296</ArticleId><ArticleId IdType="pmc">PMC9877834</ArticleId><ArticleId IdType="pubmed">36367230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D., He G., Li H., Tan H., Ji X., Lin Z., Hu J., Liu T., Xiao J., Liang X., et al. Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and SymptomsâChina, December 2022âFebruary 2023. China CDC Wkly. 2023;28:369â373. doi: 10.46234/ccdcw2023.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2023.070</ArticleId><ArticleId IdType="pmc">PMC10184382</ArticleId><ArticleId IdType="pubmed">37197449</ArticleId></ArticleIdList></Reference><Reference><Citation>The Central Peopleâs Government of the China   [(accessed on 24 December 2022)]; Available online:  https://www.gov.cn/</Citation></Reference><Reference><Citation>Hu J., Gao Q., He C., Huang A., Tang N., Wang K. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2. Genes Dis. 2020;7:551â557. doi: 10.1016/j.gendis.2020.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2020.07.006</ArticleId><ArticleId IdType="pmc">PMC7366953</ArticleId><ArticleId IdType="pubmed">32837985</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi R.K., Chen I.P., Ma T., Syed A.M., Brazer N., Saldhi P., Simoneau C.R., Ciling A., Khalid M.M., Sreekumar B., et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022;607:351â355. doi: 10.1038/s41586-022-04865-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04865-0</ArticleId><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K., Karim F., Cele S., Reedoy K., San J.E., Lustig G., Tegally H., Rosenberg Y., Bernstein M., Jule Z., et al. Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature. 2022;607:356â359. doi: 10.1038/s41586-022-04830-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04830-x</ArticleId><ArticleId IdType="pmc">PMC9279144</ArticleId><ArticleId IdType="pubmed">35523247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.Y., Chiew C.J., Pang D., Lee V.J., Ong B., Lye D.C., Tan K.B. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: A national cohort study. Lancet Infect. Dis. 2023;23:799â805. doi: 10.1016/S1473-3099(23)00060-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00060-9</ArticleId><ArticleId IdType="pmc">PMC10306341</ArticleId><ArticleId IdType="pubmed">36924786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz N., Ware H., Ma X., Li Z., Hosseini R., Caoa C., Selemond A., Whelan M., Premji Z., Issa H., et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression. Lancet Infect. Dis. 2023;23:556â567. doi: 10.1016/S1473-3099(22)00801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00801-5</ArticleId><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Sprouse K.R., Bowen J.E., Joshi A., Franko N., Navarro M.J., Stewart C., Cameroni E., McCallum M., Goecker E.A., et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022;185:872â880.e3. doi: 10.1016/j.cell.2022.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.011</ArticleId><ArticleId IdType="pmc">PMC8769922</ArticleId><ArticleId IdType="pubmed">35123650</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevo L., Cahen-Peretz A., Vorontsov O., Frenkel R., Kabessa M., Cohen S.M., Hamrani A., Oiknine-Djian E., Lipschuetz M., Goldman-Wohl D., et al. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose. Am. J. Obstet. Gynecol. 2022;227:486.e1â486.e10. doi: 10.1016/j.ajog.2022.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2022.04.010</ArticleId><ArticleId IdType="pmc">PMC9008977</ArticleId><ArticleId IdType="pubmed">35430228</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz F.M., Bond N.H., Maccato M., Pinell P., Hammill H.A., Swamy G.K., Walter E.B., Jackson L.A., Englund J.A., Edwards M.S., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: A randomized clinical trial. JAMA. 2014;311:1760â1769. doi: 10.1001/jama.2014.3633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.3633</ArticleId><ArticleId IdType="pmc">PMC4333147</ArticleId><ArticleId IdType="pubmed">24794369</ArticleId></ArticleIdList></Reference><Reference><Citation>Rottenstreich A., Zarbiv G., Oiknine-Djian E., Vorontsov O., Zigron R., Kleinstern G., Porat S., Wolf D.G. Kinetics of Maternally Derived Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Infants in Relation to the Timing of Antenatal Vaccination. Clin. Infect. Dis. 2023;76:e274âe279. doi: 10.1093/cid/ciac480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac480</ArticleId><ArticleId IdType="pmc">PMC9214162</ArticleId><ArticleId IdType="pubmed">35717644</ArticleId></ArticleIdList></Reference><Reference><Citation>Shook L.L., Atyeo C.G., Yonker L.M., Fasano A., Gray K.J., Alter G., Edlow A.G. Durability of Anti-Spike Antibodies in Infants after Maternal COVID-19 Vaccination or Natural Infection. JAMA. 2022;327:1087â1089. doi: 10.1001/jama.2022.1206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.1206</ArticleId><ArticleId IdType="pmc">PMC8822441</ArticleId><ArticleId IdType="pubmed">35129576</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zelm M.C. Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine or not? Sci. Immunol. 2022;7:eabq5901. doi: 10.1126/sciimmunol.abq5901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq5901</ArticleId><ArticleId IdType="pubmed">35653497</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A., Irie T., Suzuki R., Maemura T., Nasser H., Uriu K., Kosugi Y., Shirakawa K., Sadamasu K., Kimura I., et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602:300â306. doi: 10.1038/s41586-021-04266-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04266-9</ArticleId><ArticleId IdType="pmc">PMC8828475</ArticleId><ArticleId IdType="pubmed">34823256</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinn J., Sedighim S., Kirby K.A., Hohmann S., Hameed A.B., Jolley J., Nguyen N.T. Characteristics and Outcomes of Women with COVID-19 Giving Birth at US Academic Centers during the COVID-19 Pandemic. JAMA Netw. Open. 2021;4:e2120456. doi: 10.1001/jamanetworkopen.2021.20456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.20456</ArticleId><ArticleId IdType="pmc">PMC8358731</ArticleId><ArticleId IdType="pubmed">34379123</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde-Agudelo A., Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2022;226:68â89.e3. doi: 10.1016/j.ajog.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8294655</ArticleId><ArticleId IdType="pubmed">34302772</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBolt C.A., Bianco A., Limaye M.A., Silverstein J., Penfield C.A., Roman A.S., Rosenberg H.M., Ferrara L., Lambert C., Khoury R., et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am. J. Obstet. Gynecol. 2021;224:510.e1â510.e12. doi: 10.1016/j.ajog.2020.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.11.022</ArticleId><ArticleId IdType="pmc">PMC7677036</ArticleId><ArticleId IdType="pubmed">33221292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen S.A., Jamieson D.J. Covid-19 Vaccination during PregnancyâTwo for the Price of One. N. Engl. J. Med. 2022;387:178â179. doi: 10.1056/NEJMe2206730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2206730</ArticleId><ArticleId IdType="pmc">PMC9258746</ArticleId><ArticleId IdType="pubmed">35731898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>